*Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama;
†MacuLogix, Hummelstown, Pennsylvania; and
‡Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.
Reprint requests: Cynthia Owsley, PhD, Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, 700 South 18th Street, Suite 609, Birmingham, AL 35294-0009; e-mail: [email protected]
Supported by the National Institutes of Health (R01AG04212, R01EY06109, R01EY024378), the EyeSight Foundation of Alabama, the Dorsett Davis Discovery Fund, Alfreda J. Schueler Trust, and Research to Prevent Blindness Inc.
Paper presented at the annual meeting of the Association for Research in Vision and Ophthalmology, Denver, CO, May 5, 2015.
C. Owsley is a patent holder on the device used to measure dark adaptation in this study. G. R. Jackson is an employee of MacuLogix, the manufacturer of the device used to measure dark adaptation in this study. The remaining authors have no financial/conflicting interests to disclose.
